Gene Query: PDLIM1

Dataset Description Geneva Score
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 116.41
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 116.41
CHCHD2 gene KO effect in iPSC drived motor neurons 91.05
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 83.51
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 82.58
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 82.58
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 71.97
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 71.1
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 71.1
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 54.23
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 54.23
Gene expression changes associated with resistance to tagraxofusp (SL-401) 52.01
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 49.33
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 47.78
Depicting early human development and germ cell origin with porcine embryos 46.79
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 46.16
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 46.12
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 46.12
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 44.58
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 44.58
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 44.56
RNA-seq analysis of AML cells in response to ASLAN003 43.89
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 43.55
The interplay between SOX4 and SMAD3 in the context of breast cancer 40.41
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 39.46
Transcriptome analysis of kidney organoids 39.38
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 38.33
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 37.83
CHCHD10 gene KO effect in iPSC drived motor neurons 37.65
TCF7L1 knockdown in pancreatic cancer 37.54
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 36.74
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 36.23
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 36.23
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 36.11
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 35.22
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 35.0
Nucleoporin-mediated regulation of cell identity genes 33.69
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 33.67
Crizotinib v. DMSO in SW480 cells 33.67
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 33.43
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 33.36
Regulation of Lipids is Central to Replicative Senescence 33.32
Transcriptome profiling of Normal and Cancerous Prostate Cells 32.84
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 32.72
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 32.15
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 32.15
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 31.84
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 31.64
hTERT promotes cell adhesion and migration independent of telomerase activity 31.63
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 31.45
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 31.45
METTL3 promotes translation in human cancer cells 30.96
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 30.82
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 30.76
Lipid degradation promotes prostate cancer cell survival 30.63
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 30.59
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 30.0
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 29.84
RNA-seq data from human lymphoma cell lines 29.67
ChIP-seq and RNA-seq from human lymphoma cell lines 29.67
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 29.57
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 29.54
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 28.92
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 28.67
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 28.04
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 27.85
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 27.81
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 27.66
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 27.39
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 25.98
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 25.98
GATA3-mediated chromatin reprogramming in breast cancer cells 25.78
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 25.41
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 24.99
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 24.99
Role of CD133 molecule in WNT response and renal repair 24.61
TFAP2C signalling in human fibroblasts 24.43
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 24.38
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 24.38
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 24.07
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 23.93
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 23.78
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 23.52
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 23.41
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 23.23
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 23.0
AUF-1 affected genes in human skin cells 22.98
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 22.64
Nonpregnant and term pregnant human myometrial tissues 22.49
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 22.49
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 22.34
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 22.32
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 22.25
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 22.14
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 21.83
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 21.51
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 21.35
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 21.31
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 21.26
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 21.23
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 21.23
RNA-Seq from early time points in the kidney differentiation protocol 21.23
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 21.17
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 20.85
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 20.42
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 20.27
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 20.24
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 20.21
MYCi361 regulates MYC target genes 20.1
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 19.94
A prostate cancer chromatin interaction map 19.91
Genome-wide mapping of TEL-AML1 targets in acute leukemia 19.85
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 19.79
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 19.45
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 19.45
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 19.41
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 19.26
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 19.23
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 19.23
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 19.22
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 18.96
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 18.8
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 18.8
Global expression profiles in cardiac progenitor cells generated by ISX-9 18.56
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 18.56
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 18.54
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 18.54
Effect of BMP inhibition or stimulation of primary human keratinocytes 18.32
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 18.32
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 18.29
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 18.29
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 18.1
Lineage specific differentiation is influenced by state of human pluripotency 18.1
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 17.91
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 17.91
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 17.82
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 17.79
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 17.57
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 17.55
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 17.5
Neurofibroma 17.5
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 17.31
Toxoplasma gondii infection of human retinal pigment epithelial cells 17.29
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 17.25
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 17.15
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 17.08
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 17.08
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 17.0
HNF1 regulates critical functions of the human epididymis epithelium. 16.95
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 16.95
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 16.79
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 16.68
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 16.68
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 16.62
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 16.48
BCL11B 16.43
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 16.42
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 16.39
RNA expression following TMPRSS11B overexpression or depletion 16.38
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 16.23
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 16.14
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 16.13
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 15.86
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 15.84
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 15.83
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 15.82
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 15.78
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 15.78
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 15.74
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 15.73
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 15.73
Impact of dieldrin on transcription in Jurkat T cells 15.7
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 15.54
Primary human trophoblast from term placenta 15.53
A transcriptome-wide divergence in protein translation scales with LIN28B expression 15.48
RNA-seq of IL-4 stimulated human keratinocytes 15.41
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 15.4
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 15.34
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 15.31
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 15.3
Control of prostate tumour growth by the long non-coding RNA GHSROS 15.25
Epigenomic landscape during organ formation in human early embryos 15.21
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 15.16
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 15.13
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 15.12
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 15.09
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 14.97
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 14.97
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 14.96
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 14.96
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 14.92
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 14.92
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 14.92
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 14.9
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 14.86
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 14.84
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 14.73
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 14.73
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 14.71
Examining serotonergic neuron differentiation from human iPSCs 14.66
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 14.65
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 14.62
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 14.57
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 14.5
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 14.4
Transcriptional profiles of normal human mature B cells 14.39
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 14.35
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 14.27
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 14.13
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 14.09
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 14.07
NR2F2 study 14.07
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 14.06
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 13.94
Modeling Familial Cancer with iPSC Approaches 13.93
RNA-seq of CD33 KO and control HSPCs 13.82
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 13.79
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 13.78
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 13.7
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 13.65
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 13.61
Identification of the role of polydom in neurofibromas 13.49
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 13.48
Neonatal and adult human testis defined at the single-cell level 13.47
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 13.46
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 13.45
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 13.43
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 13.42
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 13.42
WRN knockout effects upon gene expression in SW48 and OVK18 13.34
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 13.25
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 13.2
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 13.2
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 13.13
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 13.13
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 13.11
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 13.11
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 13.1
Differentially expressed vascular development genes for iPSC-ECs from CDI 12.96
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 12.88
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 12.83
ARID1A and ARID1B loss in HCT116 cells 12.82
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 12.82
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 12.82
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 12.82
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 12.76
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 12.71
Expression profiling of etoposide-induced senescent cells 12.62
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 12.61
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 12.5
mRNA-sequencing of breast cancer subtypes and normal tissue 12.49
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 12.42
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 12.33
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 12.3
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 12.3
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 12.24
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 12.08
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 12.05
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 12.04
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 12.02
N6-methyladenine DNA Modification in Glioblastoma 12.02
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 12.01
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 11.99
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 11.99
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 11.97
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 11.97
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 11.91
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 11.84
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 11.84
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 11.83
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 11.78
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 11.78
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 11.75
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 11.63
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 11.61
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 11.5
Transcriptome analysis of BAP1 knockout and restoration 11.5
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 11.48
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 11.48
High-throughput sequencing of pluripotent cells 11.45
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 11.38
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 11.37
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 11.26
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 11.15
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 11.15
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 11.0
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 10.93
Transcriptional responses of melanoma cells to BRAF inhibition 10.92
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 10.92
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 10.91
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 10.88
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 10.88
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 10.87
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 10.83
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 10.73
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 10.72
RNA Seq of HMVEC under hypoxia 10.72
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 10.68
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 10.65
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 10.55
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 10.42
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 10.36
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 10.27
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 10.21
A practical evaluation of alignment algorithms for RNA variant calling analysis 10.19
Expression profiles of the four human major ectodermal lineages 10.08
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 10.07
Generation of trichogenic adipose-derived stem cells by expression of three factors 9.99
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 9.94
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 9.94
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 9.93
CHD1 regulates cell fate determination by activation of differentiation-induced genes 9.86
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 9.77
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 9.67
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 9.61
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 9.52
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 9.46
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 9.32
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 9.31
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 9.17
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 9.16
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 9.15
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 9.09
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 9.05
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 9.05
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 8.97
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 8.96
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 8.77
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 8.69
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 8.69
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 8.56
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 8.54
A single cell reference map for human blood and tissue T cell activation 8.5
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 8.45
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 8.45
Total RNA sequencing of APC mutant and wt colonic organoids 8.35
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 8.32
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 8.28
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 8.26
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 8.26
RNA seq_PDX2_SHP099 8.09
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 7.95
Hypoxic transcriptome of SQ20B human head and neck cancer cells 7.93
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 7.88
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 7.82
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 7.74
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 7.69
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 7.67
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 7.52
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 7.42
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 7.42
mRNA expression in human DAOY cells 7.39
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 7.28
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 7.21
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 7.05
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 6.98
The DPYSL2 gene connects mTOR and schizophrenia 6.82
hESC neural differentiation 6.78
RNA-seq analysis of gene expression patterns during hESC neural differentiation 6.78
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 6.72
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 6.69
Redifferentiation of expanded human islet β cells by inhibition of ARX 6.66
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 6.62
Leucegene: AML sequencing (part 6) 6.51
Efficient derivation of microglia-like cells from human pluripotent stem cells 6.29
MRTF activates TEAD-YAP target gene expression 6.29
An optimization system for isolating and sequencing of single human colon cancer cells 6.29
JAK dependent survival of ALK- ALCL 6.25
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 6.18
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 6.14
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.01
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 5.98
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 5.94
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 5.88
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.85
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 5.83
miR-93 Targets in Human Endothelial Cells 5.8
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.76
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 5.68
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 5.52
FGF2 regulation of gene expression in stable inducible Neurons 5.49
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 5.45
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 5.42
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 5.41
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 5.36
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 5.36
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 5.29
The bromodomain protein BRD4 regulates splicing during heat shock 5.21
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 5.19
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 5.08
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 5.07
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 4.85
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 4.85
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 4.83
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 4.74
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 4.58
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 4.57
Iron response of HepG2 cells 4.52
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 4.48
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 4.43
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 4.43
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 4.42
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 4.32
RNA-sequencing of healthy human skeletal myocytes 4.22
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 4.14
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 4.14
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 4.09
Dynamic 3D chromosomal landscapes in acute leukemia 4.09
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 4.06
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 3.97
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 3.89
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 3.85
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 3.75
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 3.74
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 3.72
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 3.7
Leucegene: ALL sequencing 3.52
Transcriptome sequencing of K-562 cells 3.5
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 3.45
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 3.45
SF3B1 Degron knockdown RNA-seq 3.27
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 3.27
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 3.26
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 3.26
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.17
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 3.11
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 3.07
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 3.02
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 3.02
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 2.99
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.91
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 2.85
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.79
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 2.76
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 2.68
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.66
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 2.53
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 2.52
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.51
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 2.51
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 2.45
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 2.35
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 2.35
RNA-Seq in PWS iPSC-derived neurons 2.35
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 2.27
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 2.27
Comparative Analysis of Cas9 Activators Across Multiple Species 2.21
Human ovarian granulosa cell transcriptome 2.19
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 2.17
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.08
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.03
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 1.98
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 1.98
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 1.97
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.89
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.89
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  1.89
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 1.85
Epigenomic conservation of transposable element silencing [RNA-seq] 1.82
Epigenomic conservation of transposable element silencing 1.82
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.8
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.78
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.5
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 1.46
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.42
Differential gene expression profiles in imatinib-resistant cell lines 1.39
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.26
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.26
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.2
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 1.2
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.16
RNAseq of cell lines with knocked in ESR1 mutations 1.16
Transcriptome Profiling of Human Primary Monocytes 1.14
Single-cell analysis of adult human ovary using 10X genomics 1.08
Global transcriptome analysis of WT versus HEB-/- hESCs 1.06
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.98
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.98
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 0.7
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 0.69
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 0.57
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.56
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.54
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.54
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.46
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 0.46
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 0.46
Dilated cardiomyopathy vs Myocarditis 0.44
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.41
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.4
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.39
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.39
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 0.18
RNA sequencing of T-ALL (COG study) 0.17
Analyses of T-ALL (COG study) 0.17
MHC Transcriptomic landscape at haplotype-specific resolution 0.16
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.14
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.12
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.12
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.07


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation